Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LTA4H | P09960 | 7/20 | 0.67 |
| ▸ | TSHR | P16473 | 1/20 | 0.67 |
| ▸ | MAOA | P21397 | 2/20 | 0.56 |
| ▸ | NR1H2 | P55055 | 1/20 | 0.56 |
| ▸ | BAX | Q07812 | 1/20 | 0.56 |
| ▸ | FFAR1 | O14842 | 2/20 | 0.56 |
| ▸ | EPHX2 | P34913 | 2/20 | 0.56 |
| ▸ | FFAR4 | Q5NUL3 | 1/20 | 0.56 |
| ▸ | SOS1 | Q07889 | 1/20 | 0.50 |
| ▸ | HSPB1 | P04792 | 1/20 | 0.50 |
| ▸ | CA1 | P00915 | 1/20 | 0.50 |
| ▸ | CA2 | P00918 | 1/20 | 0.50 |
| ▸ | NR3C1 | P04150 | 1/20 | 0.47 |
| ▸ | KDM1A | O60341 | 1/20 | 0.47 |
| ▸ | MAOB | P27338 | 1/20 | 0.47 |
| ▸ | SCN9A | Q15858 | 1/20 | 0.47 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.47 |
| ▸ | MAPT | P10636 | 1/20 | 0.47 |
| ▸ | MEN1 | O00255 | 1/20 | 0.47 |
| ▸ | HTT | P42858 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Ammonia Solution, Strong SCHEMBL4263312 | 0.97 | LTA4H (0.63) | LTA4HTSHRMAOANR1H2BAX | |
| Phosphine SCHEMBL23466364 | 0.97 | LTA4H (0.63) | LTA4HTSHRMAOANR1H2BAX | |
| Methylamine SCHEMBL28014353 | 0.93 | LTA4H (0.57) | LTA4HTSHRMAOANR1H2BAX | |
| SCHEMBL6290683 | 0.88 | SOS1 (0.58) | LTA4HTSHRFFAR1EPHX2FFAR4 | |
| SCHEMBL6289867 | 0.88 | SOS1 (0.58) | LTA4HTSHRFFAR1EPHX2FFAR4 | |
| SCHEMBL351854 | 0.88 | SOS1 (0.58) | LTA4HTSHRFFAR1EPHX2FFAR4 | |
| SCHEMBL7940611 | 0.87 | SCN9A (0.51) | LTA4HTSHRMAOANR1H2BAX | |
| SCHEMBL27479068 | 0.87 | FFAR1 (0.60) | LTA4HTSHRNR1H2BAXFFAR1 | |
| SCHEMBL12386985 | 0.87 | LTA4H (0.50) | LTA4HTSHRMAOANR1H2BAX | |
| SCHEMBL6293841 | 0.86 | L3MBTL1 (0.58) | LTA4HTSHRFFAR1EPHX2FFAR4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 291 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2369670-B1 | Non-aqueous electrolytic solution for lithium secondary battery and lithium secondary battery using the same | UBE INDUSTRIES (JP) | 2016-03-23 | — | — | EP | claimed |
| US-8722255-B2 | Non-aqueous electrolytic solution for lithium secondary battery and lithium secondary battery using the same | UBE INDUSTRIES, LTD. (JP) | 2014-05-13 | — | — | US | claimed |
| EP-1650826-B1 | NONAQUEOUS ELECTROLYTIC SOLUTION FOR LITHIUM SECONDARY BATTERY AND LITHIUM SECONDARY BATTERY USING SAME | UBE INDUSTRIES (JP) | 2013-05-01 | — | — | EP | claimed |
| US-20120301760-A1 | NONAQUEOUS ELECTROLYTE SECONDARY BATTERY WITH AN ELECTROLYTE INCLUDING A LITHIUM BORON COMPOUND | SANYO GS SOFT ENERGY CO., LTD. (JP) | 2012-11-29 | — | — | US | claimed |
| US-20120183864-A1 | NON-AQUEOUS ELECTROLYTIC SOLUTION FOR LITHIUM SECONDARY BATTERY AND LITHIUM SECONDARY BATTERY USING THE SAME | UBE INDUSTRIES, LTD. (JP) | 2012-07-19 | — | — | US | claimed |
| US-8163427-B2 | Nonaqueous electrolytic solution for lithium secondary battery and lithium secondary battery using the same | UBE INDUSTRIES, LTD. (JP) | 2012-04-24 | — | — | US | claimed |
| CN-102256944-A | Sphingosine-1-phosphate receptor antagonists | EXELIXIS INC | 2011-11-23 | — | — | CN | claimed |
| EP-2369670-A1 | Non-aqueous electrolytic solution for lithium secondary battery and lithium secondary battery using the same | Ube Industries, Ltd. (JP) | 2011-09-28 | — | — | EP | claimed |
| US-20090197167-A1 | Fluorinated Additives For Lithium Ion Batteries | SOLVAY FLUOR GMBH (DE) | 2009-08-06 | — | — | US | claimed |
| CN-100517853-C | Nonaqueous electrolytic solution for lithium secondary battery and lithium secondary battery using the same | UBE INDUSTRIES (JP) | 2009-07-22 | — | — | CN | claimed |
| US-20080193852-A1 | Positive electrode; oxides of lithium and a transition metal, a negative electrode which adsorbs/desorbs lithium; andan electrolyte of lithium bisoxalatoborate or a lithium dioxaborolane ring complex; decreasing initial battery thickness and hydrogen gas generated in initial charging | SANYO ELECTRIC CO., LTD. (JP) | 2008-08-14 | — | — | US | claimed |
| EP-1938404-A1 | FLUORINATED ADDITIVES FOR LITHIUM ION BATTERIES | Solvay Fluor GmbH (DE) | 2008-07-02 | — | — | EP | claimed |
| WO-2007042471-A1 | FLUORINATED ADDITIVES FOR LITHIUM ION BATTERIES | SOLVAY FLUOR GMBH (DE) | 2007-04-19 | — | — | WO | claimed |
| CN-1886124-A | Method for inhibiting production of remnant lipoproteins | JAPAN TOBACCO INC (JP) | 2006-12-27 | — | — | CN | claimed |
| CN-1853307-A | Nonaqueous electrolytic solution for lithium secondary battery and lithium secondary battery using the same | UBE INDUSTRIES (JP) | 2006-10-25 | — | — | CN | claimed |
| US-20060177742-A1 | Nonaqueous electrolytic solution for lithium secondary battery and lithium secondary battery using the same | MU IONIC SOLUTIONS CORPORATION (JP) | 2006-08-10 | — | — | US | claimed |
| EP-1670446-A2 | METHOD OF INHIBITING REMNANT LIPOPROTEIN PRODUCTION | JAPAN TOBACCO INC. (JP) | 2006-06-21 | — | — | EP | claimed |
| EP-1650826-A1 | NONAQUEOUS ELECTROLYTIC SOLUTION FOR LITHIUM SECONDARY BATTERY AND LITHIUM SECONDARY BATTERY USING SAME | Ube Industries, Ltd. (JP) | 2006-04-26 | — | — | EP | claimed |
| WO-2005030185-A2 | METHOD OF INHIBITING REMNANT LIPOPROTEIN PRODUCTION | JAPAN TOBACCO INC. (JP) | 2005-04-07 | — | — | WO | claimed |
| US-12336981-B2 | Compounds and compositions for the inhibition of NAMPT | VALO HEALTH, INC. (US) | 2025-06-24 | — | — | US | disclosed |
| EP-4380943-A1 | METHOD FOR THE SILYLATION OF A C-H BOND WITH A SILYLATED DIAZENE | SORBONNE UNIVERSITE (FR) | 2024-06-12 | — | — | EP | disclosed |
| US-20240158574-A1 | POLYETHERETHERKETONE AND METHOD FOR PRODUCING THE SAME | IDEMITSU KOSAN CO.,LTD. (JP) | 2024-05-16 | — | — | US | disclosed |
| CN-111840271-B | Novel application of glycoside derivative | 北京盈科瑞创新药物研究有限公司 | 2024-05-14 | — | — | CN | disclosed |
| CN-114761399-B | Imidazole carboxamide derivatives as bruton's tyrosine kinase inhibitors | 河南知微生物医药有限公司 | 2024-03-26 | — | — | CN | disclosed |
| CN-115151549-B | Photochromic cyclic compound and curable composition containing the same | 株式会社德山 | 2023-12-19 | — | — | CN | disclosed |
| CN-117203262-A | Polyether-ether-ketone and method for producing same | 出光兴产株式会社 | 2023-12-08 | — | — | CN | disclosed |
| WO-2023225625-A2 | BIFUNCTIONAL DEGRADERS COMPRISING ELECTROPHILIC PROTACS THAT ENGAGE DCAF1 AND PHARMACEUTICAL COMPOSITIONS COMPRISING THE SAME | THE SCRIPPS RESEARCH INSTITUTE (US) | 2023-11-23 | — | — | WO | disclosed |
| US-20230346753-A1 | NOVEL COMPOUNDS AND COMPOSITIONS FOR THE INHIBITION OF NAMPT | VALO HEALTH, INC. | 2023-11-02 | — | — | US | disclosed |
| US-20230346753-A1 | NOVEL COMPOUNDS AND COMPOSITIONS FOR THE INHIBITION OF NAMPT | VALO HEALTH, INC. | 2023-11-02 | — | — | US | disclosed |
| CN-114685456-B | 2, 5-diketopiperazine compound derivative, preparation method thereof, pharmaceutical composition and application thereof | 大连万众益生大健康有限公司 | 2023-10-10 | — | — | CN | disclosed |
| CN-116640298-A | Method for preparing benzene end-capped polyaryletherketone by end capping | 山东君昊高性能聚合物有限公司 | 2023-08-25 | — | — | CN | disclosed |
| CN-111471032-B | Synthesis method of glycoside derivative, intermediate and application thereof | 北京盈科瑞创新药物研究有限公司 | 2023-08-01 | — | — | CN | disclosed |
| US-20230204572-A1 | Engineered Biosensors in an Encapsulated and Deployable System (EBEADS) for Environmental Chemical Detection | THE JOHNS HOPKINS UNIVERSITY (US) | 2023-06-29 | — | — | US | disclosed |
| CN-111471040-B | Synthesis method of glycoside derivative, intermediate and application thereof | 北京盈科瑞创新药物研究有限公司 | 2023-06-02 | — | — | CN | disclosed |
| US-20230167067-A1 | PHOTOREDOX-CATALYZED DIRECT C-H FUNCTIONALIZATION OF ARENES | UNIV NORTH CAROLINA CHAPEL HILL (US) | 2023-06-01 | — | — | US | disclosed |
| US-20230167067-A1 | PHOTOREDOX-CATALYZED DIRECT C-H FUNCTIONALIZATION OF ARENES | UNIV NORTH CAROLINA CHAPEL HILL (US) | 2023-06-01 | — | — | US | disclosed |
| CN-111471031-B | Glycoside derivative and preparation method and application thereof | 北京盈科瑞创新药物研究有限公司 | 2023-05-16 | — | — | CN | disclosed |
| US-11584720-B2 | Photoredox-catalyzed direct C-H functionalization of arenes | THE UNIVERSITY OF NORTH CAROLINA AT CHAPEL HILL (US) | 2023-02-21 | — | — | US | disclosed |
| WO-2023012494-A1 | METHOD FOR THE SILYLATION OF A C-H BOND WITH A SILYLATED DIAZENE | SORBONNE UNIVERSITE (FR) | 2023-02-09 | — | — | WO | disclosed |
| WO-2023012494-A1 | METHOD FOR THE SILYLATION OF A C-H BOND WITH A SILYLATED DIAZENE | SORBONNE UNIVERSITE (FR) | 2023-02-09 | — | — | WO | disclosed |
| US-11547701-B2 | Compounds and compositions for the inhibition of NAMPT | VALO HEALTH, INC. (US) | 2023-01-10 | — | — | US | disclosed |
| CN-115417751-A | Method for hydroxylation of benzene ring C-H phenol | 中山大学 | 2022-12-02 | — | — | CN | disclosed |
| CN-110294685-B | Amide based on electron-rich fluoroarene and preparation method thereof | 华中师范大学 | 2022-11-11 | — | — | CN | disclosed |
| WO-2022230934-A1 | POLYETHER ETHER KETONE AND METHOD FOR PRODUCING SAME | 出光興産株式会社 | 2022-11-03 | — | — | WO | disclosed |
| CN-113054107-B | Organic solution combination for coating organic solar cell | 广州追光科技有限公司 | 2022-10-21 | — | — | CN | disclosed |
| CN-115151549-A | Photochromic cyclic compound and curable composition containing same | 株式会社德山 | 2022-10-04 | — | — | CN | disclosed |
| WO-2022144002-A1 | DERIVATIVE OF 2,5-DIKETOPIPERAZINE COMPOUND, AND PREPARATION METHOD THEREFOR, PHARMACEUTICAL COMPOSITION THEREOF AND USE THEREOF | 大连万众益生大健康有限公司 | 2022-07-07 | — | — | WO | disclosed |
| US-20220169581-A1 | DIRECT AROMATIC CARBON-OXYGEN AND CARBON-HYDROGEN BOND FUNCTIONALIZATION VIA ORGANIC PHOTOREDOX CATALYST | THE UNIVERSITY OF NORTH CAROLINA AT CHAPEL HILL | 2022-06-02 | — | — | US | disclosed |
| US-11230517-B2 | Method for aromatic fluorination | THE REGENTS OF THE UNIVERSITY OF MICHIGAN (US) | 2022-01-25 | — | — | US | disclosed |
| US-20210252011-A1 | TREATMENT OF GLIOBLASTOMA WITH FASN INHIBITORS | CORNELL UNIVERSITY | 2021-08-19 | — | — | US | disclosed |
| US-20210246147-A1 | PIPERIDINE DERIVATIVES AND COMPOSITIONS FOR THE INHIBITION OF NICOTINAMIDE PHOSPHORIBOSYLTRANSFERASE (NAMPT) | Valo Health, LLC | 2021-08-12 | — | — | US | disclosed |
| CN-113054107-A | Organic solution combination for coating organic solar cell | 广州追光科技有限公司 | 2021-06-29 | — | — | CN | disclosed |
| US-10995078-B2 | Compounds and compositions for inhibition of FASN | FORMA THERAPEUTICS, INC. (US) | 2021-05-04 | — | — | US | disclosed |
| US-10913696-B2 | Method for aromatic fluorination | DOW GLOBAL TECHNOLOGIES LLC (US) | 2021-02-09 | — | — | US | disclosed |
| EP-3587406-B1 | 2-HYDROXY-1-{4-[(4-PHENYLPHENYL)CARBONYL]PIPERAZIN-1-YL}ETHAN-1-ONE DERIVATIVES AND RELATED COMPOUNDS AS FATTY ACID SYNTHASE (FASN) INHIBITORS FOR THE TREATMENT OF CANCER | FORMA THERAPEUTICS INC (US) | 2021-01-27 | — | — | EP | disclosed |
| US-20200407292-A1 | METHOD FOR AROMATIC FLUORINATION | CORTEVA AGRISCIENCE LLC | 2020-12-31 | — | — | US | disclosed |
| US-20200347025-A1 | COMPOUNDS AND COMPOSITIONS FOR INHIBITION OF FASN | FORMA THERAPEUTICS, INC. | 2020-11-05 | — | — | US | disclosed |
| CN-111840271-A | New application of glycoside derivatives | 北京盈科瑞创新药物研究有限公司 | 2020-10-30 | — | — | CN | disclosed |
| CN-111471031-A | Glucoside derivative and preparation method and application thereof | 北京盈科瑞创新药物研究有限公司 | 2020-07-31 | — | — | CN | disclosed |
| CN-111471032-A | Synthesis method of glycoside derivatives, intermediate and application thereof | 北京盈科瑞创新药物研究有限公司 | 2020-07-31 | — | — | CN | disclosed |
| CN-111471040-A | Synthesis method of glycoside derivatives, intermediate and application thereof | 北京盈科瑞创新药物研究有限公司 | 2020-07-31 | — | — | CN | disclosed |
| US-20200239390-A1 | METHOD FOR AROMATIC FLUORINATION | CORTEVA AGRISCIENCE LLC | 2020-07-30 | — | — | US | disclosed |
| EP-3452437-B1 | METHOD FOR AROMATIC FLUORINATION | DOW GLOBAL TECHNOLOGIES LLC (US) | 2020-07-29 | — | — | EP | disclosed |
| US-10654776-B2 | Method for aromatic fluorination | DOW GLOBAL TECHNOLOGIES LLC (US) | 2020-05-19 | — | — | US | disclosed |
| US-10647695-B2 | Compounds and compositions for the inhibition of NAMPT | FORMA TM, LLC (US) | 2020-05-12 | — | — | US | disclosed |
| US-10472342-B2 | Compounds and compositions for inhibition of FASN | FORMA THERAPEUTICS, INC. (US) | 2019-11-12 | — | — | US | disclosed |
| US-10457655-B2 | Compounds and compositions for inhibition of FASN | FORMA THERAPEUTICS, INC. (US) | 2019-10-29 | — | — | US | disclosed |
| US-20190322676-A1 | CERAMIDE GALACTOSYLTRANSFERASE INHIBITORS FOR THE TREATMENT OF DISEASE | BIOMARIN PHARM INC (US) | 2019-10-24 | — | — | US | disclosed |
| US-10450286-B2 | Compounds and compositions for inhibition of FASN | FORMA THERAPEUTICS, INC. (US) | 2019-10-22 | — | — | US | disclosed |
| CN-110256489-A | A kind of preparation method of alkylphosphines acylate | 苏州大学 | 2019-09-20 | — | — | CN | disclosed |
| CN-110229187-A | A method of alkylphosphines acylate is prepared by peroxide | 苏州大学 | 2019-09-13 | — | — | CN | disclosed |
| US-20190270721-A1 | NOVEL COMPOUNDS AND COMPOSITIONS FOR THE INHIBITION OF NAMPT | Valo Health, LLC | 2019-09-05 | — | — | US | disclosed |
| US-10399951-B2 | Compounds and compositions for inhibition of FASN | FORMA THERAPEUTICS, INC. (US) | 2019-09-03 | — | — | US | disclosed |
| US-10399947-B2 | Photoredox-catalyzed direct C—H functionalization of arenes | THE UNIVERSITY OF NORTH CAROLINA AT CHAPEL HILL (US) | 2019-09-03 | — | — | US | disclosed |
| US-20190241533-A1 | NOVEL COMPOUNDS AND COMPOSITIONS FOR INHIBITION OF FASN | FORMA THERAPEUTICS, INC. | 2019-08-08 | — | — | US | disclosed |
| US-20190241532-A1 | NOVEL COMPOUNDS AND COMPOSITIONS FOR INHIBITION OF FASN | FORMA THERAPEUTICS, INC. | 2019-08-08 | — | — | US | disclosed |
| EP-2968316-B1 | 2-HYDROXY-1-{4-[(4-PHENYLPHENYL)CARBONYL]PIPERAZIN-1-YL}ETHAN-1-ONE DERIVATIVES AND RELATED COMPOUNDS AS FATTY ACID SYNTHASE (FASN) INHIBITORS FOR THE TREATMENT OF CANCER | FORMA THERAPEUTICS INC (US) | 2019-08-07 | — | — | EP | disclosed |
| US-20190202758-A1 | METHOD FOR AROMATIC FLUORINATION | CORTEVA AGRISCIENCE LLC | 2019-07-04 | — | — | US | disclosed |
| US-10106492-B2 | Fluorinated carbonyl compounds comprising a triple bond, methods for their manufacture and uses thereof | SOLVAY SA (BE) | 2018-10-23 | — | — | US | disclosed |
| WO-2018118838-A1 | CERAMIDE GALACTOSYLTRANSFERASE INHIBITORS FOR THE TREATMENT OF DISEASE | BIOMARIN PHARMACEUTICAL INC. (US) | 2018-06-28 | — | — | WO | disclosed |
| US-20180148414-A1 | PHOTOREDOX-CATALYZED DIRECT C-H FUNCTIONALIZATION OF ARENES | THE UNIVERSITY OF NORTH CAROLINA AT CHAPEL HILL | 2018-05-31 | — | — | US | disclosed |
| US-20180148414-A1 | PHOTOREDOX-CATALYZED DIRECT C-H FUNCTIONALIZATION OF ARENES | THE UNIVERSITY OF NORTH CAROLINA AT CHAPEL HILL | 2018-05-31 | — | — | US | disclosed |
| US-9969673-B2 | Process for the manufacture of 1, 1′-difluorosubstituted dialkyl carbonates, isomers thereof and electrolyte compositions containing them | SOLVAY S.A. (BE) | 2018-05-15 | — | — | US | disclosed |
| US-9963452-B2 | Methods, compounds, and compositions for inhibition of ROS | AUGUSTA PHARMACEUTICALS INC. (US) | 2018-05-08 | — | — | US | disclosed |
| EP-2871180-B1 | 2-AMINONICOTINIC ACID ESTER DERIVATIVE AND BACTERICIDE CONTAINING SAME AS ACTIVE INGREDIENT | AGRO KANESHO CO LTD (JP) | 2018-03-21 | — | — | EP | disclosed |
| US-20180050997-A1 | NOVEL COMPOUNDS AND COMPOSITIONS FOR INHIBITION OF FASN | FORMA THERAPEUTICS, INC. | 2018-02-22 | — | — | US | disclosed |
| EP-2788313-B1 | PROCESS FOR THE MANUFACTURE OF 1,1'-DIFLUOROSUBSTITUTED DIALKYL CARBONATES | SOLVAY (BE) | 2018-02-21 | — | — | EP | disclosed |
| US-9882198-B2 | High performance lithium battery electrodes by self-assembly processing | THE REGENTS OF THE UNIVERSITY OF MICHIGAN (US) | 2018-01-30 | — | — | US | disclosed |
| US-9825331-B2 | Fluorinated derivatives of meldrum's acid, a method for the preparation of the same, and their use as a solvent additive | SOLVAY SA (BE) | 2017-11-21 | — | — | US | disclosed |
| EP-3243816-A1 | PROCESS FOR PREPARING A SUBSTITUTED AROMATIC OR HETEROAROMATIC HYDROCARBON AND ITS USE | Studiengesellschaft Kohle mbH (DE) | 2017-11-15 | — | — | EP | disclosed |
| EP-3243816-A1 | PROCESS FOR PREPARING A SUBSTITUTED AROMATIC OR HETEROAROMATIC HYDROCARBON AND ITS USE | Studiengesellschaft Kohle mbH (DE) | 2017-11-15 | — | — | EP | disclosed |
| WO-2017192564-A1 | METHOD FOR AROMATIC FLUORINATION | DOW GLOBAL TECHNOLOGIES LLC (US) | 2017-11-09 | — | — | WO | disclosed |
| WO-2017189613-A1 | METHODS OF USING FASN INHIBITORS | FORMA THERAPEUTICS, INC. (US) | 2017-11-02 | — | — | WO | disclosed |
| US-20170312273-A1 | METHODS OF USING FASN INHIBITORS | FORMA THERAPEUTICS, INC. | 2017-11-02 | — | — | US | disclosed |
| EP-2220083-B1 | IMIDAZO[1,2-A]PYRIDINE DERIVATIVES AND THEIR USE AS POSITIVE ALLOSTERIC MODULATORS OF MGLUR2 RECEPTORS | JANSSEN PHARMACEUTICALS INC (US) | 2017-07-19 | — | — | EP | disclosed |
| US-9676721-B2 | Compounds and compositions for the inhibition of NAMPT | FORMA TM, LLC (US) | 2017-06-13 | — | — | US | disclosed |
| CN-106833466-A | A kind of high-ductility fire retarding epoxide resin adhesive | 中国科学院长春应用化学研究所 | 2017-06-13 | — | — | CN | disclosed |
| US-20170137441-A1 | Piperidine Derivatives And Compositions For the Inhibition Of Nicotinamide Phosphoribosyltransferase (NAMPT) | VALO EARLY DISCOVERY, INC. | 2017-05-18 | — | — | US | disclosed |
| US-9555039-B2 | Piperidine derivatives and compositions for the inhibition of nicotinamide phosphoribosyltransferase (NAMPT) | FORMA TM, LLC. (US) | 2017-01-31 | — | — | US | disclosed |
| EP-2785703-B1 | 5-Fluorinated derivatives of Meldrum's acid (5-fluoro-1,3-dioxane-4,6-dione derivatives), methods for their preparation and their use as solvent additives in lithium ion batteries. | SOLVAY (BE) | 2017-01-11 | — | — | EP | disclosed |
| EP-2873110-B1 | FLUORINATED CARBONYL COMPOUNDS COMPRISING A TRIPLE BOND, METHODS FOR THEIR MANUFACTURE AND USES THEREOF | SOLVAY (BE) | 2016-12-21 | — | — | EP | disclosed |
| WO-2016154998-A1 | PYRAZOLOPYRIMIDINE DERIVATIVE, MANUFACTURING METHOD, PHARMACEUTICAL COMPOSITION, AND USE THEREOF | 安润医药科技（苏州）有限公司 | 2016-10-06 | — | — | WO | disclosed |
| US-9452959-B2 | Fluorination of aryl compounds | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2016-09-27 | — | — | US | disclosed |
| EP-3026125-A1 | Means and methods for bioremediating glycol ethers | ATOTECH Deutschland GmbH (DE) | 2016-06-01 | — | — | EP | disclosed |
| EP-2611777-B1 | N-(4-{[PYRIDIN-3-YL-METHYL)CARBAMOYL]AMINO}BENZENE-SULFONE DERIVATIVES AS NAMPT INHIBITORS FOR THERAPY OF DISEASES SUCH AS CANCER | FORMA TM LLC (US) | 2016-05-11 | — | — | EP | disclosed |
| CN-105492437-A | Substituted benzofuranyl and benzoxazolyl compounds and uses thereof | KARYOPHARM THERAPEUTICS INC | 2016-04-13 | — | — | CN | disclosed |
| EP-1979978-B1 | NONAQUEOUS ELECTROLYTE INCLUDING DIPHENYL ETHER AND LITHIUM SECONDARY BATTERY USING THEREOF | PANAX ETEC CO LTD (KR) | 2016-04-06 | — | — | EP | disclosed |
| EP-2369670-B1 | Non-aqueous electrolytic solution for lithium secondary battery and lithium secondary battery using the same | UBE INDUSTRIES (JP) | 2016-03-23 | — | — | EP | disclosed |
| US-20160031890-A1 | NOVEL METHODS, COMPOUNDS, AND COMPOSITIONS FOR INHIBITION OF ROS | GRUENEBERG, Dorre A. | 2016-02-04 | — | — | US | disclosed |
| CN-105246890-A | Pyrrolo[2, 3-b]pyridine cdk9 kinase inhibitors | ABBVIE INC | 2016-01-13 | — | — | CN | disclosed |
| US-20160002188-A1 | NOVEL COMPOUNDS AND COMPOSITIONS FOR INHIBITION OF FASN | FORMA THERAPEUTICS, INC. | 2016-01-07 | — | — | US | disclosed |
| CN-105008344-A | Bruton's tyrosine kinase inhibitors | PFIZER | 2015-10-28 | — | — | CN | disclosed |
| US-9169209-B2 | Compounds and compositions for the inhibition of NAMPT | FORMA TM, LLC (US) | 2015-10-27 | — | — | US | disclosed |
| US-9169209-B2 | Compounds and compositions for the inhibition of NAMPT | FORMA TM, LLC (US) | 2015-10-27 | — | — | US | disclosed |
| US-20150250789-A1 | QUINAZOLINE COMPOUNDS AS SODIUM CHANNEL BLOCKERS | PURDUE PHARMA L.P. | 2015-09-10 | — | — | US | disclosed |
| US-20150221929-A1 | High Performance Lithium Battery Electrodes By Self-Assembly Processing | THE REGENTS OF THE UNIVERSITY OF MICHIGAN | 2015-08-06 | — | — | US | disclosed |
| EP-2611778-B1 | GUANIDINE COMPOUNDS AND COMPOSITIONS FOR THE INHIBITION OF NAMPT | FORMA TM LLC (US) | 2015-08-05 | — | — | EP | disclosed |
| US-20150191423-A1 | FLUORINATED CARBONYL COMPOUNDS COMPRISING A TRIPLE BOND, METHODS FOR THEIR MANUFACTURE AND USES THEREOF | SOLVAY SA (BE) | 2015-07-09 | — | — | US | disclosed |
| US-20150175508-A1 | FLUORINATION OF ARYL COMPOUNDS | NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT | 2015-06-25 | — | — | US | disclosed |
| EP-2873110-A1 | FLUORINATED CARBONYL COMPOUNDS COMPRISING A TRIPLE BOND, METHODS FOR THEIR MANUFACTURE AND USES THEREOF | SOLVAY SA (BE) | 2015-05-20 | — | — | EP | disclosed |
| US-8981035-B2 | Production method of poly (phenylene ether ether ketone) | TORAY INDUSTRIES, INC. (JP) | 2015-03-17 | — | — | US | disclosed |
| EP-2825694-A2 | AFFINITY REAGANTS FOR PROTEIN PURIFICATION | Impossible Foods Inc. (US) | 2015-01-21 | — | — | EP | disclosed |
| US-20140342221-A1 | PROCESS FOR THE MANUFACTURE OF 1, 1'-DIFLUOROSUBSTITUTED DIALKYL CARBONATES, ISOMERS THEREOF AND ELECTROLYTE COMPOSITIONS CONTAINING THEM | SYENSQO SA (BE) | 2014-11-20 | — | — | US | disclosed |
| WO-2014141129-A9 | NOVEL METHODS, COMPOUNDS, AND COMPOSITIONS FOR INHIBITION OF ROS | GRUENEBERG DORRE A (US) | 2014-11-06 | — | — | WO | disclosed |
| US-20140322618-A1 | FLUORINATED DERIVATIVES OF MELDRUM'S ACID, A METHOD FOR THE PREPARATION OF THE SAME, AND THEIR USE AS A SOLVENT ADDITIVE | SOLVAY SA (BE) | 2014-10-30 | — | — | US | disclosed |
| EP-2788313-A1 | PROCESS FOR THE MANUFACTURE OF 1, 1'-DIFLUOROSUBSTITUTED DIALKYL CARBONATES, ISOMERS THEREOF AND ELECTROLYTE COMPOSITIONS CONTAINING THEM | Solvay SA (BE) | 2014-10-15 | — | — | EP | disclosed |
| WO-2014164749-A1 | NOVEL COMPOUNDS AND COMPOSITIONS FOR INHIBITION OF FASN | FORMA THERAPEUTICS, INC. (US) | 2014-10-09 | — | — | WO | disclosed |
| WO-2014164767-A1 | NOVEL COMPOUNDS AND COMPOSITIONS FOR INHIBITION OF FASN | FORMA THERAPEUTICS, INC. (US) | 2014-10-09 | — | — | WO | disclosed |
| EP-2785703-A1 | FLUORINATED DERIVATIVES OF MELDRUM'S ACID, A METHOD FOR THE PREPARATION OF THE SAME, AND THEIR USE AS A SOLVENT ADDITIVE | Solvay SA (BE) | 2014-10-08 | — | — | EP | disclosed |
| US-20140294805-A1 | NOVEL COMPOUNDS AND COMPOSITIONS FOR THE INHIBITION OF NAMPT | VALO EARLY DISCOVERY, INC. | 2014-10-02 | — | — | US | disclosed |
| US-20140275057-A1 | NOVEL COMPOUNDS AND COMPOSITIONS FOR THE INHIBITION OF NAMPT | Valo Health, LLC | 2014-09-18 | — | — | US | disclosed |
| US-20140275057-A1 | NOVEL COMPOUNDS AND COMPOSITIONS FOR THE INHIBITION OF NAMPT | Valo Health, LLC | 2014-09-18 | — | — | US | disclosed |
| WO-2014141129-A2 | NOVEL METHODS, COMPOUNDS, AND COMPOSITIONS FOR INHIBITION OF ROS | GRUENEBERG DORRE A (US) | 2014-09-18 | — | — | WO | disclosed |
| US-20140248240-A1 | PIPERIDINE DERIVATIVES AND COMPOSITIONS FOR THE INHIBITION OF NICOTINAMIDE PHOSPHORIBOSYLTRANSFERASE (NAMPT) | VALO HEALTH, INC. | 2014-09-04 | — | — | US | disclosed |
| EP-2305217-B1 | Method for the preparation of pharmaceutical compositions comprising a solid amorphous dispersion of cholesteryl ester transfer protein inhibitors | BEND RES INC (US) | 2014-07-30 | — | — | EP | disclosed |
| US-8722255-B2 | Non-aqueous electrolytic solution for lithium secondary battery and lithium secondary battery using the same | UBE INDUSTRIES, LTD. (JP) | 2014-05-13 | — | — | US | disclosed |
| US-20140128565-A1 | PRODUCTION METHOD OF POLY (PHENYLENE ETHER ETHER KETONE) | TORAY INDUSTRIES, INC. (JP) | 2014-05-08 | — | — | US | disclosed |
| EP-2725050-A1 | METHOD FOR PRODUCING POLYPHENYLENE ETHER ETHER KETONE | Toray Industries, Inc. (JP) | 2014-04-30 | — | — | EP | disclosed |
| EP-2702631-A1 | LITHIUM AIR BATTERY CELL | Solvay SA (BE) | 2014-03-05 | — | — | EP | disclosed |
| WO-2014027003-A1 | USE OF LOW CONCENTRATIONS OF FLUORINATED ORGANIC COMPOUNDS AS SOLVENT ADDITIVES | SOLVAY SA (BE) | 2014-02-20 | — | — | WO | disclosed |
| US-20140045078-A1 | LITHIUM AIR BATTERY CELL | SOLVAY SA (BE) | 2014-02-13 | — | — | US | disclosed |
| EP-2266960-B1 | Aryl-substituted pyrazoles, imidazoles, oxazoles, thiazoles and pyrroles as anticonvulsants | EURO CELTIQUE SA (LU) | 2014-01-22 | — | — | EP | disclosed |
| EP-2266960-B1 | Aryl-substituted pyrazoles, imidazoles, oxazoles, thiazoles and pyrroles as anticonvulsants | EURO CELTIQUE SA (LU) | 2014-01-22 | — | — | EP | disclosed |
| WO-2014009377-A1 | FLUORINATED CARBONYL COMPOUNDS COMPRISING A TRIPLE BOND, METHODS FOR THEIR MANUFACTURE AND USES THEREOF | SOLVAY SA (BE) | 2014-01-16 | — | — | WO | disclosed |
| WO-2013174697-A1 | USE OF FLUORINATED 2 -METHOXYMALONIC ACID ESTERS IN ELECTROLYTE OR SOLVENT COMPOSITIONS | SOLVAY SA (BE) | 2013-11-28 | — | — | WO | disclosed |
| EP-2667444-A1 | Use of fluorinated 2-methoxymalonic acid esters in electrolyte or solvent compositions | SOLVAY SA (BE) | 2013-11-27 | — | — | EP | disclosed |
| US-20130295051-A1 | NOVEL COMPOUNDS AND COMPOSITIONS FOR THE INHIBITION OF NAMPT | VALO HEALTH, INC. | 2013-11-07 | — | — | US | disclosed |
| US-20130273034-A1 | NOVEL COMPOUNDS AND COMPOSITIONS FOR THE INHIBITION OF NAMPT | VALO EARLY DISCOVERY, INC. | 2013-10-17 | — | — | US | disclosed |
| US-20130273034-A1 | NOVEL COMPOUNDS AND COMPOSITIONS FOR THE INHIBITION OF NAMPT | VALO EARLY DISCOVERY, INC. | 2013-10-17 | — | — | US | disclosed |
| EP-2649053-A1 | PYRIMIDINONE COMPOUNDS FOR USE IN THE TREATMENT OF DISEASES OR CONDITIONS MEDIATED BY LP - PLA2 | Glaxo Group Limited (GB) | 2013-10-16 | — | — | EP | disclosed |
| CN-103330703-A | Method of inhibiting remnant lipoprotein production | JAPAN TOBACCO INC | 2013-10-02 | — | — | CN | disclosed |
| WO-2013138793-A2 | AFFINITY REAGANTS FOR PROTEIN PURIFICATION | MARAXI, INC. (US) | 2013-09-19 | — | — | WO | disclosed |
| US-8524194-B2 | Radiolabelled MMP selective compounds | ACADEMISCH MEDISCH CENTRUM BIJ DE UNIVERSITEIT VAN AMSTERDAM (NL) | 2013-09-03 | — | — | US | disclosed |
| WO-2013083418-A1 | PROCESS FOR THE MANUFACTURE OF 1, 1'-DIFLUOROSUBSTITUTED DIALKYL CARBONATES, ISOMERS THEREOF AND ELECTROLYTE COMPOSITIONS CONTAINING THEM | SOLVAY SA (BE) | 2013-06-13 | — | — | WO | disclosed |
| WO-2012031196-A9 | 4- { [ ( PYRIDIN- 3 - YL -METHYL) AMINOCARBONYL] AMINO} BENZENE - SULFONE DERIVATIVES AS NAMPT INHIBITORS FOR THERAPY OF DISEASES SUCH AS CANCER | FORMA TM, LLC (US) | 2013-06-13 | — | — | WO | disclosed |
| EP-2602241-A1 | Process for the manufacture of 1, 1'-difluorosubstituted dialkyl carbonates, isomers thereof and electrolyte compositions containing them | SOLVAY SA (BE) | 2013-06-12 | — | — | EP | disclosed |
| WO-2013079397-A1 | FLUORINATED DERIVATIVES OF MELDRUM'S ACID, A METHOD FOR THE PREPARATION OF THE SAME, AND THEIR USE AS A SOLVENT ADDITIVE | SOLVAY SA (BE) | 2013-06-06 | — | — | WO | disclosed |
| EP-1650826-B1 | NONAQUEOUS ELECTROLYTIC SOLUTION FOR LITHIUM SECONDARY BATTERY AND LITHIUM SECONDARY BATTERY USING SAME | UBE INDUSTRIES (JP) | 2013-05-01 | — | — | EP | disclosed |
| US-20120301760-A1 | NONAQUEOUS ELECTROLYTE SECONDARY BATTERY WITH AN ELECTROLYTE INCLUDING A LITHIUM BORON COMPOUND | SANYO GS SOFT ENERGY CO., LTD. (JP) | 2012-11-29 | — | — | US | disclosed |
| WO-2012154194-A1 | PIPERIDINE DERIVATIVES AND COMPOSITIONS FOR THE INHIBITION OF NICOTINAMIDE PHOSPHORIBOSYLTRANSFERASE (NAMPT) | FORMA TM, LLC (US) | 2012-11-15 | — | — | WO | disclosed |
| WO-2012150952-A1 | NOVEL COMPOUNDS AND COMPOSITIONS FOR THE INHIBITION OF NAMPT | FORMA TM, LLC (US) | 2012-11-08 | — | — | WO | disclosed |
| WO-2012146525-A1 | LITHIUM AIR BATTERY CELL | SOLVAY SA (BE) | 2012-11-01 | — | — | WO | disclosed |
| EP-2494648-A1 | LITHIUM SULFUR BATTERY | Solvay Fluor GmbH (DE) | 2012-09-05 | — | — | EP | disclosed |
| US-20120214043-A1 | Lithium sulfur battery | SOLVAY FLUOR GMBH (DE) | 2012-08-23 | — | — | US | disclosed |
| US-20120183864-A1 | NON-AQUEOUS ELECTROLYTIC SOLUTION FOR LITHIUM SECONDARY BATTERY AND LITHIUM SECONDARY BATTERY USING THE SAME | UBE INDUSTRIES, LTD. (JP) | 2012-07-19 | — | — | US | disclosed |
| WO-2012076435-A1 | PYRIMIDINONE COMPOUNDS FOR USE IN THE TREATMENT OF DISEASES OR CONDITIONS MEDIATED BY LP - PLA2 | GLAXO GROUP LIMITED (GB) | 2012-06-14 | — | — | WO | disclosed |
| US-8163427-B2 | Nonaqueous electrolytic solution for lithium secondary battery and lithium secondary battery using the same | UBE INDUSTRIES, LTD. (JP) | 2012-04-24 | — | — | US | disclosed |
| WO-2012031197-A1 | NOVEL COMPOUNDS AND COMPOSITIONS FOR THE INHIBITION OF NAMPT | FORMA THERAPEUTICS, INC. (US) | 2012-03-08 | — | — | WO | disclosed |
| WO-2012031199-A1 | GUANIDINE COMPOUNDS AND COMPOSITIONS FOR THE INHIBITION OF NAMPT | FORMA THERAPEUTICS, INC. (US) | 2012-03-08 | — | — | WO | disclosed |
| WO-2012031196-A1 | 4- { [ ( PYRIDIN- 3 - YL -METHYL) AMINOCARBONYL] AMINO} BENZENE - SULFONE DERIVATIVES AS NAMPT INHIBITORS FOR THERAPY OF DISEASES SUCH AS CANCER | FORMA THERAPEUTICS, INC. (US) | 2012-03-08 | — | — | WO | disclosed |
| EP-2369670-A1 | Non-aqueous electrolytic solution for lithium secondary battery and lithium secondary battery using the same | Ube Industries, Ltd. (JP) | 2011-09-28 | — | — | EP | disclosed |
| EP-1840188-B1 | A composition comprising at least one type of liquid crystal | SONY DEUTSCHLAND GMBH (DE) | 2011-09-07 | — | — | EP | disclosed |
| US-20110171133-A1 | RADIOLABELLED MMP SELECTIVE COMPOUNDS | VERENIGING VOOR CHRISTELIJK HOGER ONDERWIJS, WETENSCHAPPELIJK ONDERZOEK EN PATIENTENZORG (NL) | 2011-07-14 | — | — | US | disclosed |
| WO-2011051275-A1 | LITHIUM SULFUR BATTERY | SOLVAY FLUOR GMBH (DE) | 2011-05-05 | — | — | WO | disclosed |
| EP-2285759-A1 | RADIOLABELLED MMP SELECTIVE COMPOUNDS | Academisch Medisch Centrum bij de Universiteit van Amsterdam (NL) | 2011-02-23 | — | — | EP | disclosed |
| US-20110009454-A1 | COMPOSITION FOR AGRICULTURAL USE FOR CONTROLLING OR PREVENTING PLANT DISEASES CAUSED BY PLANT PATHOGENS | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2011-01-13 | — | — | US | disclosed |
| EP-1869001-B1 | SUBSTITUTED TETRAHYDROISOCHINOLINES AS MMP INHIBITORS, RELATED PRODUCTION METHOD AND USE AS MEDICINE | SANOFI AVENTIS (FR) | 2011-01-12 | — | — | EP | disclosed |
| EP-2266960-A2 | Aryl-substituted pyrazoles, imidazoles, oxazoles, thiazoles and pyrroles as anticonvulsants | EURO-CELTIQUE S.A. (LU) | 2010-12-29 | — | — | EP | disclosed |
| EP-2266960-A2 | Aryl-substituted pyrazoles, imidazoles, oxazoles, thiazoles and pyrroles as anticonvulsants | EURO-CELTIQUE S.A. (LU) | 2010-12-29 | — | — | EP | disclosed |
| US-7858619-B2 | Substituted tetrahydroisochinolines as MMP inhibitors, related production method and use as medicine | SANOFI-AVENTIS (FR) | 2010-12-28 | — | — | US | disclosed |
| US-7838089-B2 | with biphenylcyclohexane-based skeleton; nematic at room temperature, improved response; paraelectric | SONY CORPORATION (JP) | 2010-11-23 | — | — | US | disclosed |
| US-7838089-B2 | with biphenylcyclohexane-based skeleton; nematic at room temperature, improved response; paraelectric | SONY CORPORATION (JP) | 2010-11-23 | — | — | US | disclosed |
| US-7838089-B2 | with biphenylcyclohexane-based skeleton; nematic at room temperature, improved response; paraelectric | SONY CORPORATION (JP) | 2010-11-23 | — | — | US | disclosed |
| EP-2248423-A1 | COMPOSITION FOR AGRICULTURAL USE FOR CONTROLLING OR PREVENTING PLANT DISEASES CAUSED BY PLANT PATHOGENS | Sumitomo Chemical Company, Limited (JP) | 2010-11-10 | — | — | EP | disclosed |
| EP-1173169-B1 | ARYL SUBSTITUTED PYRAZOLES, IMIDAZOLES, OXAZOLES, THIAZOLES AND PYRROLES, AND THE USE THEREOF | EURO CELTIQUE SA (LU) | 2010-05-12 | — | — | EP | disclosed |
| EP-1173169-B1 | ARYL SUBSTITUTED PYRAZOLES, IMIDAZOLES, OXAZOLES, THIAZOLES AND PYRROLES, AND THE USE THEREOF | EURO CELTIQUE SA (LU) | 2010-05-12 | — | — | EP | disclosed |
| WO-2009139634-A1 | RADIOLABELLED MMP SELECTIVE COMPOUNDS | ACADEMISCH MEDISCH CENTRUM BIJ DE UNIVERSITEIT VAN AMSTERDAM (NL) | 2009-11-19 | — | — | WO | disclosed |
| WO-2009139633-A1 | RADIOLABELLED MMP SELECTIVE COMPOUNDS | ACADEMISCH MEDISCH CENTRUM BIJ DE UNIVERSITEIT VAN AMSTERDAM (NL) | 2009-11-19 | — | — | WO | disclosed |
| EP-2119690-A1 | Radiolabelled MMP selective compounds | Academisch Medisch Centrum bij de Universiteit van Amsterdam (NL) | 2009-11-18 | — | — | EP | disclosed |
| US-7595130-B2 | Battery separator and lithium secondary battery | UBE INDUSTRIES, LTD. (JP) | 2009-09-29 | — | — | US | disclosed |
| US-20090197167-A1 | Fluorinated Additives For Lithium Ion Batteries | SOLVAY FLUOR GMBH (DE) | 2009-08-06 | — | — | US | disclosed |
| EP-1465880-B1 | 5-SULPHANYL-4H-1,2,4-TRIAZOLE DERIVATIVES AND THEIR USE TO TREAT DISORDERS ASSOCIATED WITH SOMATOSTATINE | IPSEN PHARMA (FR) | 2009-08-05 | — | — | EP | disclosed |
| CN-100517853-C | Nonaqueous electrolytic solution for lithium secondary battery and lithium secondary battery using the same | UBE INDUSTRIES (JP) | 2009-07-22 | — | — | CN | disclosed |
| US-20090168009-A1 | with biphenylcyclohexane-based skeleton; nematic at room temperature, improved response; paraelectric | SONY CORPORATION (JP) | 2009-07-02 | — | — | US | disclosed |
| US-20090168009-A1 | with biphenylcyclohexane-based skeleton; nematic at room temperature, improved response; paraelectric | SONY CORPORATION (JP) | 2009-07-02 | — | — | US | disclosed |
| US-20090168009-A1 | with biphenylcyclohexane-based skeleton; nematic at room temperature, improved response; paraelectric | SONY CORPORATION (JP) | 2009-07-02 | — | — | US | disclosed |
| EP-2028186-A2 | Hepatitis C inhibitor tri-peptides | BOEHRINGER INGELHEIM (CANADA) LTD. (CA) | 2009-02-25 | — | — | EP | disclosed |
| US-20090023075-A1 | Nonaqueous electrolyte including Diphenyl ether and lithium secondary battery using thereof | PANAX ETEC CO., LTD (KR) | 2009-01-22 | — | — | US | disclosed |
| CN-101342162-A | Method of inhibiting remnant lipoprotein production | JAPAN TOBACCO INC (JP) | 2009-01-14 | — | — | CN | disclosed |
| US-7462600-B2 | Macrolides | PFIZER INC (US) | 2008-12-09 | — | — | US | disclosed |
| EP-1979978-A1 | NONAQUEOUS ELECTROLYTE INCLUDING DIPHENYL ETHER AND LITHIUM SECONDARY BATTERY USING THEREOF | Cheil Industries Inc. (KR) | 2008-10-15 | — | — | EP | disclosed |
| EP-1444202-B1 | NOVEL METALLOPROTEINASE INHIBITORS | ASTRAZENECA AB (SE) | 2008-10-15 | — | — | EP | disclosed |
| US-20080193852-A1 | Positive electrode; oxides of lithium and a transition metal, a negative electrode which adsorbs/desorbs lithium; andan electrolyte of lithium bisoxalatoborate or a lithium dioxaborolane ring complex; decreasing initial battery thickness and hydrogen gas generated in initial charging | SANYO ELECTRIC CO., LTD. (JP) | 2008-08-14 | — | — | US | disclosed |
| US-20080187825-A1 | Battery Separator and Lithium Secondary Battery | UBE INDUSTRIES LTD. (JP) | 2008-08-07 | — | — | US | disclosed |
| EP-1938404-A1 | FLUORINATED ADDITIVES FOR LITHIUM ION BATTERIES | Solvay Fluor GmbH (DE) | 2008-07-02 | — | — | EP | disclosed |
| EP-1918278-A1 | Sulfonylamino derivatives which inhibit matrix-degrading metalloproteinases | Novartis AG (CH) | 2008-05-07 | — | — | EP | disclosed |
| US-20080090821-A1 | SUBSTITUTED TETRAHYDROISOCHINOLINES AS MMP INHIBITORS, RELATED PRODUCTION METHOD AND USE AS MEDICINE | SANOFI-AVENTIS (FR) | 2008-04-17 | — | — | US | disclosed |
| CN-101120011-A | Macrolides | PFIZER PROD INC (US) | 2008-02-06 | — | — | CN | disclosed |
| EP-1869001-A1 | SUBSTITUTED TETRAHYDROISOCHINOLINES AS MMP INHIBITORS, RELATED PRODUCTION METHOD AND USE AS MEDICINE | Sanofi-Aventis (FR) | 2007-12-26 | — | — | EP | disclosed |
| EP-1840188-A2 | A composition comprising at least one type of liquid crystal | Sony Deutschland GmbH (DE) | 2007-10-03 | — | — | EP | disclosed |
| WO-2007081151-A1 | NONAQUEOUS ELECTROLYTE INCLUDING DIPHENYL ETHER AND LITHIUM SECONDARY BATTERY USING THEREOF | CHEIL INDUSTRIES INC. (KR) | 2007-07-19 | — | — | WO | disclosed |
| US-20070148554-A1 | Non-aqueous electrolytic solution and lithium secondary battery | UBE INDUSTRIES, LTD. (JP) | 2007-06-28 | — | — | US | disclosed |
| WO-2007042471-A1 | FLUORINATED ADDITIVES FOR LITHIUM ION BATTERIES | SOLVAY FLUOR GMBH (DE) | 2007-04-19 | — | — | WO | disclosed |
| EP-1173169-A4 | ARYL SUBSTITUTED PYRAZOLES, IMIDAZOLES, OXAZOLES, THIAZOLES AND PYRROLES, AND THE USE THEREOF | EURO CELTIQUE SA (LU) | 2007-04-04 | — | — | EP | disclosed |
| CN-1886124-A | Method for inhibiting production of remnant lipoproteins | JAPAN TOBACCO INC (JP) | 2006-12-27 | — | — | CN | disclosed |
| CN-1863511-A | Dosage forms providing controlled release cholesteryl ester transfer protein inhibitors and immediate release HMG-CoA reductase inhibitors | PFIZER (US) | 2006-11-15 | — | — | CN | disclosed |
| CN-1853307-A | Nonaqueous electrolytic solution for lithium secondary battery and lithium secondary battery using the same | UBE INDUSTRIES (JP) | 2006-10-25 | — | — | CN | disclosed |
| WO-2006102998-A1 | SUBSTITUTED TETRAHYDROISOCHINOLINES AS MMP INHIBITORS, RELATED PRODUCTION METHOD AND USE AS MEDICINE | SANOFI-AVENTIS (DE) | 2006-10-05 | — | — | WO | disclosed |
| US-20060177742-A1 | Nonaqueous electrolytic solution for lithium secondary battery and lithium secondary battery using the same | MU IONIC SOLUTIONS CORPORATION (JP) | 2006-08-10 | — | — | US | disclosed |
| US-20060135447-A1 | Macrolides | CHUPAK LOUIS S | 2006-06-22 | — | — | US | disclosed |
| EP-1670446-A2 | METHOD OF INHIBITING REMNANT LIPOPROTEIN PRODUCTION | JAPAN TOBACCO INC. (JP) | 2006-06-21 | — | — | EP | disclosed |
| EP-1650826-A1 | NONAQUEOUS ELECTROLYTIC SOLUTION FOR LITHIUM SECONDARY BATTERY AND LITHIUM SECONDARY BATTERY USING SAME | Ube Industries, Ltd. (JP) | 2006-04-26 | — | — | EP | disclosed |
| CN-1728995-A | Dosage forms comprising a cetp inhibitor and an HMG-CoA reductase inhibitor | PFIZER PROD INC (US) | 2006-02-01 | — | — | CN | disclosed |
| WO-2005117869-A1 | COMBINATIONS COMPRISING (S)-AMLODIPINE AND A CHOLESTERYL ESTER TRANSFER PROTEIN INHIBITOR, AND METHODS FOR REDUCING HYPERTENSION | SEPRACOR INC. (US) | 2005-12-15 | — | — | WO | disclosed |
| CN-1225456-C | Novel aromatic diamine and its polyimide | MITSUI CHEMICALS INC (JP) | 2005-11-02 | — | — | CN | disclosed |
| CN-1665536-A | Use of CETP inhibitors and antihypertensive agents as well as optionally HMG COA reductase inhibitors | PFIZER PROD INC (US) | 2005-09-07 | — | — | CN | disclosed |
| CN-1665537-A | Use of CETP inhibitors and optionally HMG COA reductable inhibitors and/or antihypertensive agents | PFIZER PROD INC (US) | 2005-09-07 | — | — | CN | disclosed |
| CN-1635911-A | Self-emulsifying formulations of cholesteryl ester transfer protein inhibitors | PFIZER PROD INC (US) | 2005-07-06 | — | — | CN | disclosed |
| CN-1625397-A | Controlled release pharmaceutical dosage forms of a cholesteryl ester transfer protein inhibitor | PFIZER PROD INC (US) | 2005-06-08 | — | — | CN | disclosed |
| WO-2005030185-A2 | METHOD OF INHIBITING REMNANT LIPOPROTEIN PRODUCTION | JAPAN TOBACCO INC. (JP) | 2005-04-07 | — | — | WO | disclosed |
| WO-2005000309-A2 | CHEMICAL COMPOUNDS | IONIX PHARMACEUTICALS LIMITED (GB) | 2005-01-06 | — | — | WO | disclosed |
| CN-1545421-A | Pharmaceutical composition comprising a low-solubility and/or acid-sensitive drug and a neutralized acidic polymer | �Ʒ� | 2004-11-10 | — | — | CN | disclosed |
| EP-1469831-A1 | PHARMACEUTICAL COMPOSITIONS COMPRISING A SOLID AMORPHOUS DISPERSION OF CHOLESTERYL ESTER TRANSFER PROTEIN INHIBITORS | Pfizer Products Inc. (US) | 2004-10-27 | — | — | EP | disclosed |
| WO-2004087125-A1 | AMINO ACID DERIVATIVES AS INHIBITORS OF MAMMALIAN SODIUM CHANNELS | IONIX PHARMACEUTICALS LIMITED (GB) | 2004-10-14 | — | — | WO | disclosed |
| CN-1523979-A | Pharmaceutical compositions of adsorbates of amorphous drug | �Ʒ� | 2004-08-25 | — | — | CN | disclosed |
| US-6737418-B2 | CENTRAL NERVOUS SYSTEM DISORDERS; ANTICONVULSANTS | EURO-CELTIQUE S.A. (LU) | 2004-05-18 | — | — | US | disclosed |
| EP-1401399-A2 | PHARMACEUTICAL COMPOSITIONS CONTAINING POLYMER AND DRUG ASSEMBLIES | Pfizer Products Inc. (US) | 2004-03-31 | — | — | EP | disclosed |
| EP-1181286-B1 | 3-(ARYLSULFONYLAMINO)-TETRAHYDROPYRAN-3-CARBOXYLIC ACID HYDROXAMIDES | PFIZER PROD INC (US) | 2003-11-12 | — | — | EP | disclosed |
| EP-1181285-B1 | 3-(ARYLSULFONYLAMINO)-TETRAHYDROFURAN-3-CARBOXYLIC ACID HYDROXAMIDES | PFIZER PROD INC (US) | 2003-10-08 | — | — | EP | disclosed |
| EP-0977733-B1 | ARYLSULFONYLAMINO HYDROXAMIC ACID DERIVATIVES | PFIZER PROD INC (US) | 2003-09-03 | — | — | EP | disclosed |
| WO-2003063832-A1 | PHARMACEUTICAL COMPOSITIONS COMPRISING A SOLID AMORPHOUS DISPERSION OF CHOLESTERYL ESTER TRANSFER PROTEIN INHIBITORS | PFIZER PRODUCTS INC. (US) | 2003-08-07 | — | — | WO | disclosed |
| EP-1070058-B1 | (4-ARYLSULFONYLAMINO)-TETRAHYDROPYRAN-4-CARBOXYLIC ACID HYDROXAMIDES | PFIZER PROD INC (US) | 2003-05-02 | — | — | EP | disclosed |
| US-20030069292-A1 | Aryl substituted pyrazoles, imidazoles, oxazoles, thiazoles and pyrroles, and the use thereof | EURO-CELTIQUE S.A. | 2003-04-10 | — | — | US | disclosed |
| CN-1403438-A | Novel aromatic diamine and its polyimide | MITSUI CHEMICALS INC (JP) | 2003-03-19 | — | — | CN | disclosed |
| WO-2003000226-A2 | PHARMACEUTICAL COMPOSITIONS CONTAINING POLYMER AND DRUG ASSEMBLIES | PFIZER PRODUCTS INC. (US) | 2003-01-03 | — | — | WO | disclosed |
| US-6414011-B1 | CENTRAL NERVOUS SYSTEM DISORDERS | EURO-CELTIQUE S.A. (LU) | 2002-07-02 | — | — | US | disclosed |
| US-6410580-B1 | ANTIINFLAMMATORY AGENTS, RHEUMATIC DISEASES | NOVARTIS AG (CH) | 2002-06-25 | — | — | US | disclosed |
| EP-1181286-A1 | 3-(ARYLSULFONYLAMINO)-TETRAHYDROPYRAN-3-CARBOXYLIC ACID HYDROXAMIDES | Pfizer Products Inc. (US) | 2002-02-27 | — | — | EP | disclosed |
| EP-1181285-A2 | 3-(ARYLSULFONYLAMINO)-TETRAHYDROFURAN-3-CARBOXYLIC ACID HYDROXAMIDES | Pfizer Products Inc. (US) | 2002-02-27 | — | — | EP | disclosed |
| US-6342521-B1 | DRUGS FOR TREATMENT OF ARTHRITIS | PFIZER INC. | 2002-01-29 | — | — | US | disclosed |
| EP-1173169-A1 | ARYL SUBSTITUTED PYRAZOLES, IMIDAZOLES, OXAZOLES, THIAZOLES AND PYRROLES, AND THE USE THEREOF | Euro-Celtique S.A. (LU) | 2002-01-23 | — | — | EP | disclosed |
| US-20020006920-A1 | Arylsulfonylamino hydroxamic acid derivatives | ROBINSON RALPH PELTON (US) | 2002-01-17 | — | — | US | disclosed |
| US-6303636-B1 | FOR THERAPY OF ARTHRITIS, CANCER, TISSUE ULCERATION, RESTENOSIS, PERIODONTAL DISEASE, EPIDERMOLYSIS BULLOSA, SCIERITIS, SEPSIS, SEPTIC SHOCK AND OTHER DISEASES INVOLVING THE PRODUCTION OF TUMOR NECROSIS FACTOR | PFIZER INC | 2001-10-16 | — | — | US | disclosed |
| US-6277987-B1 | FOR INHIBITING MATRIX-DEGRADING METALLOPROTEINASES IN MAMMALS | NOVARTIS AG (CH) | 2001-08-21 | — | — | US | disclosed |
| US-6242654-B1 | REACTING A PHENOLATE COMPOUND WITH AN ORGANIC FLUORINATING AGENT TO PREPARE A FLUORINE SUBSTITUTED AROMATIC COMPOUND | MITSUI CHEMICALS, INC. (JP) | 2001-06-05 | — | — | US | disclosed |
| CN-1296481-A | (4-arylsulfonylamino) -tetrahydropyran-4-carboxylic acid hydroxyamides | PFIZER PROD INC (US) | 2001-05-23 | — | — | CN | disclosed |
| US-6197810-B1 | ANTIARTHRITIC AGENTS; ANTICANCE RAGENTS; ANTIINFLAMMATORY AGENTS | PFIZER INC | 2001-03-06 | — | — | US | disclosed |
| EP-1070058-A1 | (4-ARYLSULFONYLAMINO)-TETRAHYDROPYRAN-4-CARBOXYLIC ACID HYDROXAMIDES | Pfizer Products Inc. (US) | 2001-01-24 | — | — | EP | disclosed |
| WO-2000073295-A1 | 3-(ARYLSULFONYLAMINO)-TETRAHYDROPYRAN-3-CARBOXYLIC ACID HYDROXAMIDES | PFIZER PRODUCTS INC. (US) | 2000-12-07 | — | — | WO | disclosed |
| WO-2000073294-A2 | 3-(ARYLSULFONYLAMINO)-TETRAHYDROFURAN-3-CARBOXYLIC ACID HYDROXAMIDES | PFIZER PRODUCTS INC. (US) | 2000-12-07 | — | — | WO | disclosed |
| EP-1053226-A1 | SULFONYLAMINO DERIVATIVES WHICH INHIBIT MATRIX-DEGRADING METALLOPROTEINASES | Novartis AG (CH) | 2000-11-22 | — | — | EP | disclosed |
| WO-2000057877-A1 | ARYL SUBSTITUTED PYRAZOLES, IMIDAZOLES, OXAZOLES, THIAZOLES AND PYRROLES, AND THE USE THEREOF | EURO-CELTIQUE S.A. (LU) | 2000-10-05 | — | — | WO | disclosed |
| US-6087392-A | A METALLOPROTEINASE INHIBITORS FOR INHIBITING MAMMALIAN REPROLYSIN | PFIZER INC. (US) | 2000-07-11 | — | — | US | disclosed |
| EP-1013629-A1 | Preparation process of fluorine subsituted aromatic compound | Mitsui Chemicals, Inc. (JP) | 2000-06-28 | — | — | EP | disclosed |
| EP-0977733-A1 | ARYLSULFONYLAMINO HYDROXAMIC ACID DERIVATIVES | Pfizer Products Inc. (US) | 2000-02-09 | — | — | EP | disclosed |
| EP-0966438-A1 | N-HYDROXY-BETA-SULFONYL-PROPIONAMIDE DERIVATIVES AND THEIR USE AS INHIBITORS OF MATRIX METALLOPROTEINASES | PFIZER INC. (US) | 1999-12-29 | — | — | EP | disclosed |
| WO-1999052889-A1 | (4-ARYLSULFONYLAMINO)-TETRAHYDROPYRAN-4-CARBOXYLIC ACID HYDROXAMIDES | PFIZER PRODUCTS INC. (US) | 1999-10-21 | — | — | WO | disclosed |
| WO-1999042443-A1 | SULFONYLAMINO DERIVATIVES WHICH INHIBIT MATRIX-DEGRADING METALLOPROTEINASES | NOVARTIS AG (CH) | 1999-08-26 | — | — | WO | disclosed |
| WO-1998034915-A1 | N-HYDROXY-BETA-SULFONYL-PROPIONAMIDE DERIVATIVES AND THEIR USE AS INHIBITORS OF MATRIX METALLOPROTEINASES | PFIZER INC. (US) | 1998-08-13 | — | — | WO | disclosed |
| WO-1998033768-A1 | ARYLSULFONYLAMINO HYDROXAMIC ACID DERIVATIVES | PFIZER PRODUCTS INC. (US) | 1998-08-06 | — | — | WO | disclosed |
| EP-0398692-B1 | Alkoxyiminoacetamide derivatives and their use as fungicides | SHIONOGI & CO (JP) | 1996-08-21 | — | — | EP | disclosed |
| US-5548078-A | FOR AGRICULTURE | SHIONOGI SEIYAKU KABUSHIKI KAISHA (JP) | 1996-08-20 | — | — | US | disclosed |
| EP-0724577-A1 | HETEROCYCLIC AMINES FOR TREATING ISCHAEMIC STROKES | SMITHKLINE BEECHAM PLC (GB) | 1996-08-07 | — | — | EP | disclosed |
| WO-1995011238-A1 | HETEROCYCLIC AMINES FOR TREATING ISCHAEMIC STROKES | SMITHKLINE BEECHAM PLC (GB) | 1995-04-27 | — | — | WO | disclosed |
| US-5401877-A | Agricultural fungicide | SHIONOGI SEIYAKU KABUSHIKI KAISHA (JP) | 1995-03-28 | — | — | US | disclosed |
| US-5386044-A | Polyhaloaromatic ruthenium complexes and reactions thereof | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 1995-01-31 | — | — | US | disclosed |
| EP-0629609-A1 | Process for the preparation of Alkoxyiminoacetamide derivatives and an intermediate therefor | SHIONOGI SEIYAKU KABUSHIKI KAISHA trading under the name of SHIONOGI & CO. LTD. (JP) | 1994-12-21 | — | — | EP | disclosed |
| US-5371223-A | Controlling phytopathogens | SHIONOGI SEIYAKU KABUSHIKI KAISHA (JP) | 1994-12-06 | — | — | US | disclosed |
| US-5371222-A | Intermediates | SHIONOGI SEIYAKU KABUSHIKI KAISHA (JP) | 1994-12-06 | — | — | US | disclosed |
| US-5185342-A | ALKOXYIMINOACETAMIDE DERIVATIVES AND THEIR USE AS FUNGICIDES | SHIONOGI SEIYAKU KABUSHIKI KAISHA (JP) | 1993-02-09 | — | — | US | disclosed |
| EP-0398692-A2 | Alkoxyiminoacetamide derivatives and their use as fungicides | SHIONOGI SEIYAKU KABUSHIKI KAISHA trading under the name of SHIONOGI & CO. LTD. (JP) | 1990-11-22 | — | — | EP | disclosed |
| US-4912180-A | Process for the preparation of polyarylene sulphides | BAYER AKTIENGESELLSCHAFT (DE) | 1990-03-27 | — | — | US | disclosed |
| US-4906712-A | Process for the preparation of polyarylene sulphides | BAYER AKTIENGESELLSCHAFT (DE) | 1990-03-06 | — | — | US | disclosed |
| EP-0315903-A1 | Process for producing poly(arylene sulfides) | BAYER AG (DE) | 1989-05-17 | — | — | EP | disclosed |
| EP-0315904-A1 | Process for producing poly(arylene sulfides) | BAYER AG (DE) | 1989-05-17 | — | — | EP | disclosed |
| EP-0128692-B1 | PROCESS FOR THE PREPARATION OF 4-HYDROXY-BENZOPHENONES | IMPERIAL CHEMICAL INDUSTRIES PLC (GB) | 1988-03-02 | — | — | EP | disclosed |
| US-4599452-A | Chemical process | IMPERIAL CHEMICAL INDUSTRIES PLC (GB) | 1986-07-08 | — | — | US | disclosed |
| EP-0069598-B1 | PREPARATION OF AROMATIC KETONES | RAYCHEM CORPORATION (a California corporation) (US) | 1984-12-19 | — | — | EP | disclosed |
| EP-0128692-A2 | Process for the preparation of 4-hydroxy-benzophenones | IMPERIAL CHEMICAL INDUSTRIES PLC (GB) | 1984-12-19 | — | — | EP | disclosed |
| EP-0077721-A1 | Cyclopropanecarboxylic-acid derivatives bearing an alkylthiocarbonyl group, their preparation, their use as parasiticides for plants, animals, and loci, and compositions containing them | ROUSSEL-UCLAF (FR) | 1983-04-27 | — | — | EP | disclosed |
| EP-0069598-A1 | Preparation of aromatic ketones | RAYCHEM CORPORATION (a California corporation) (US) | 1983-01-12 | — | — | EP | disclosed |
| EP-0069598-A1 | Preparation of aromatic ketones | RAYCHEM CORPORATION (a California corporation) (US) | 1983-01-12 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (48 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20200407292-A1 | METHOD FOR AROMATIC FLUORINATION | ARSA, AHR, AR | LTA4H 3745/4885TSHR 530/4885MAOA 249/4885 |
| US-20200239390-A1 | METHOD FOR AROMATIC FLUORINATION | ARSA, AHR, AR | LTA4H 3320/4885TSHR 638/4885MAOA 248/4885 |
| US-10647695-B2 | Compounds and compositions for the inhibition of NAMPT | NAMPT, NNT, NQO1 | LTA4H 3143/4885TSHR 2779/4885MAOA 101/4885 |
| US-20190241533-A1 | NOVEL COMPOUNDS AND COMPOSITIONS FOR INHIBITION OF FASN | FASN, FABP1, SCD | LTA4H 888/4885TSHR 3727/4885MAOA 1022/4885 |
| US-20060135447-A1 | Macrolides | LCAT, NOP2, HDAC6 | LTA4H 841/4885TSHR 3874/4885MAOA 1385/4885 |
| US-11584720-B2 | Photoredox-catalyzed direct C-H functionalization of arenes | PPOX, AOC2, AOC3 | LTA4H 1625/4885TSHR 2772/4885MAOA 100/4885 |
| US-20220169581-A1 | DIRECT AROMATIC CARBON-OXYGEN AND CARBON-HYDROGEN BOND FUNCTIONALIZATION VIA ORGANIC PHOTOREDOX CATALYST | PPOX, CYCS, SCO2 | LTA4H 3195/4885TSHR 2838/4885MAOA 291/4885 |
| US-20180050997-A1 | NOVEL COMPOUNDS AND COMPOSITIONS FOR INHIBITION OF FASN | FASN, FABP1, SCD | LTA4H 888/4885TSHR 3727/4885MAOA 1022/4885 |
| US-10399951-B2 | Compounds and compositions for inhibition of FASN | FASN, FABP1, SCD | LTA4H 1099/4885TSHR 3517/4885MAOA 673/4885 |
| US-20140322618-A1 | FLUORINATED DERIVATIVES OF MELDRUM'S ACID, A METHOD FOR THE PREPARATION OF THE SAME, AND THEIR USE AS A SOLVENT ADDITIVE | FXR2, FXR1, SLC10A1 | LTA4H 1415/4885TSHR 3153/4885MAOA 3254/4885 |
| US-10913696-B2 | Method for aromatic fluorination | ARSA, AHR, AR | LTA4H 3745/4885TSHR 530/4885MAOA 249/4885 |
| US-20150175508-A1 | FLUORINATION OF ARYL COMPOUNDS | AFF2, AFF1, AFF4 | LTA4H 2579/4885TSHR 841/4885MAOA 160/4885 |
| US-20110009454-A1 | COMPOSITION FOR AGRICULTURAL USE FOR CONTROLLING OR PREVENTING PLANT DISEASES CAUSED BY PLANT PATHOGENS | WIZ, TST, NAT1 | LTA4H 3410/4885TSHR 2588/4885MAOA 3447/4885 |
| US-20140342221-A1 | PROCESS FOR THE MANUFACTURE OF 1, 1'-DIFLUOROSUBSTITUTED DIALKYL CARBONATES, ISOMERS THEREOF AND ELECTROLYTE COMPOSITIONS CONTAINING THEM | ADH1C, ADH1A, ALDH1A1 | LTA4H 2359/4885TSHR 4373/4885MAOA 1082/4885 |
| US-12336981-B2 | Compounds and compositions for the inhibition of NAMPT | NAMPT, NNMT, NNT | LTA4H 2871/4885TSHR 2887/4885MAOA 115/4885 |
| US-20200347025-A1 | COMPOUNDS AND COMPOSITIONS FOR INHIBITION OF FASN | FASN, FABP1, SCD | LTA4H 881/4885TSHR 3610/4885MAOA 554/4885 |
| US-20130295051-A1 | NOVEL COMPOUNDS AND COMPOSITIONS FOR THE INHIBITION OF NAMPT | NAMPT, NNMT, NQO1 | LTA4H 2790/4885TSHR 2612/4885MAOA 211/4885 |
| US-11230517-B2 | Method for aromatic fluorination | ARSA, AHR, AR | LTA4H 3745/4885TSHR 530/4885MAOA 249/4885 |
| US-11547701-B2 | Compounds and compositions for the inhibition of NAMPT | NAMPT, NNMT, NQO1 | LTA4H 2984/4885TSHR 2846/4885MAOA 115/4885 |
| US-20190202758-A1 | METHOD FOR AROMATIC FLUORINATION | ARSA, AHR, SNRPF | LTA4H 3632/4885TSHR 558/4885MAOA 208/4885 |
| US-10399947-B2 | Photoredox-catalyzed direct C—H functionalization of arenes | PPOX, AOC2, AOC3 | LTA4H 1659/4885TSHR 2753/4885MAOA 110/4885 |
| US-20160031890-A1 | NOVEL METHODS, COMPOUNDS, AND COMPOSITIONS FOR INHIBITION OF ROS | ROS1, NOX4, NOX1 | LTA4H 3556/4885TSHR 4141/4885MAOA 1373/4885 |
| US-20140275057-A1 | NOVEL COMPOUNDS AND COMPOSITIONS FOR THE INHIBITION OF NAMPT | NAMPT, NNMT, NAPRT | LTA4H 2739/4885TSHR 2594/4885MAOA 251/4885 |
| US-20140294805-A1 | NOVEL COMPOUNDS AND COMPOSITIONS FOR THE INHIBITION OF NAMPT | NAMPT, NNMT, NQO1 | LTA4H 2761/4885TSHR 2455/4885MAOA 226/4885 |
| US-20210246147-A1 | PIPERIDINE DERIVATIVES AND COMPOSITIONS FOR THE INHIBITION OF NICOTINAMIDE PHOSPHORIBOSYLTRANSFERASE (NAMPT) | NAMPT, NAPRT, NNMT | LTA4H 2579/4885TSHR 3065/4885MAOA 221/4885 |
| US-20170312273-A1 | METHODS OF USING FASN INHIBITORS | FASN, IL1RN, CCR1 | LTA4H 306/4885TSHR 3453/4885MAOA 2823/4885 |
| US-10472342-B2 | Compounds and compositions for inhibition of FASN | FASN, FABP1, SCD | LTA4H 881/4885TSHR 3610/4885MAOA 554/4885 |
| US-20210252011-A1 | TREATMENT OF GLIOBLASTOMA WITH FASN INHIBITORS | AIFM2, FABP7, FASN | LTA4H 2557/4885TSHR 3070/4885MAOA 4133/4885 |
| US-20080090821-A1 | SUBSTITUTED TETRAHYDROISOCHINOLINES AS MMP INHIBITORS, RELATED PRODUCTION METHOD AND USE AS MEDICINE | MMP9, MMP3, MMP2 | LTA4H 114/4885TSHR 2700/4885MAOA 123/4885 |
| US-20030069292-A1 | Aryl substituted pyrazoles, imidazoles, oxazoles, thiazoles and pyrroles, and the use thereof | GRIK5, GRIN3A, GRIK3 | LTA4H 234/4885TSHR 931/4885MAOA 2397/4885 |
| US-20110171133-A1 | RADIOLABELLED MMP SELECTIVE COMPOUNDS | MMP1, MMP3, MMP9 | LTA4H 506/4885TSHR 2896/4885MAOA 175/4885 |
| US-10450286-B2 | Compounds and compositions for inhibition of FASN | FASN, FABP1, SCD | LTA4H 881/4885TSHR 3610/4885MAOA 554/4885 |
| US-20120214043-A1 | Lithium sulfur battery | PFAS, PFKFB1, PFKFB2 | LTA4H 2355/4885TSHR 1957/4885MAOA 4252/4885 |
| US-20020006920-A1 | Arylsulfonylamino hydroxamic acid derivatives | MMP8, MMP1, MMP10 | LTA4H 3358/4885TSHR 3352/4885MAOA 2967/4885 |
| US-20160002188-A1 | NOVEL COMPOUNDS AND COMPOSITIONS FOR INHIBITION OF FASN | FASN, FABP1, SCD | LTA4H 888/4885TSHR 3727/4885MAOA 1022/4885 |
| US-20190241532-A1 | NOVEL COMPOUNDS AND COMPOSITIONS FOR INHIBITION OF FASN | FASN, FABP1, SCD | LTA4H 888/4885TSHR 3727/4885MAOA 1022/4885 |
| US-10654776-B2 | Method for aromatic fluorination | ARSA, AHR, SNRPF | LTA4H 3632/4885TSHR 558/4885MAOA 208/4885 |
| US-20190322676-A1 | CERAMIDE GALACTOSYLTRANSFERASE INHIBITORS FOR THE TREATMENT OF DISEASE | UGCG, MAN2B1, GBA1 | LTA4H 503/4885TSHR 4258/4885MAOA 1137/4885 |
| US-20170137441-A1 | Piperidine Derivatives And Compositions For the Inhibition Of Nicotinamide Phosphoribosyltransferase (NAMPT) | NAMPT, NAPRT, NNMT | LTA4H 2639/4885TSHR 3302/4885MAOA 286/4885 |
| US-20140248240-A1 | PIPERIDINE DERIVATIVES AND COMPOSITIONS FOR THE INHIBITION OF NICOTINAMIDE PHOSPHORIBOSYLTRANSFERASE (NAMPT) | NAMPT, NAPRT, NNMT | LTA4H 2579/4885TSHR 3065/4885MAOA 221/4885 |
| US-20180148414-A1 | PHOTOREDOX-CATALYZED DIRECT C-H FUNCTIONALIZATION OF ARENES | PPOX, AOC2, AOC3 | LTA4H 1625/4885TSHR 2772/4885MAOA 100/4885 |
| US-20150250789-A1 | QUINAZOLINE COMPOUNDS AS SODIUM CHANNEL BLOCKERS | SCN4A, TRPV1, SCN1B | LTA4H 607/4885TSHR 1585/4885MAOA 1171/4885 |
| US-20190270721-A1 | NOVEL COMPOUNDS AND COMPOSITIONS FOR THE INHIBITION OF NAMPT | NAMPT, HAMP, NQO1 | LTA4H 3047/4885TSHR 2416/4885MAOA 142/4885 |
| US-10995078-B2 | Compounds and compositions for inhibition of FASN | FASN, FABP1, SCD | LTA4H 881/4885TSHR 3610/4885MAOA 554/4885 |
| US-10457655-B2 | Compounds and compositions for inhibition of FASN | FASN, FABP1, SCD | LTA4H 881/4885TSHR 3610/4885MAOA 554/4885 |
| US-20230167067-A1 | PHOTOREDOX-CATALYZED DIRECT C-H FUNCTIONALIZATION OF ARENES | PPOX, AOC2, AOC3 | LTA4H 1625/4885TSHR 2772/4885MAOA 100/4885 |
| US-20230346753-A1 | NOVEL COMPOUNDS AND COMPOSITIONS FOR THE INHIBITION OF NAMPT | NAMPT, NNMT, NQO1 | LTA4H 2761/4885TSHR 2455/4885MAOA 226/4885 |
| US-20130273034-A1 | NOVEL COMPOUNDS AND COMPOSITIONS FOR THE INHIBITION OF NAMPT | NAMPT, NNMT, NQO1 | LTA4H 2761/4885TSHR 2455/4885MAOA 226/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.